suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19
Objectives: Elevated soluble urokinase Plasminogen Activator Receptor (suPAR) is a biomarker associated with adverse outcomes. We aimed to investigate the associations between plasma suPAR levels (testing the cut-offs ⩽4, 4-6, and ⩾6 ng/mL) with risk of 14-day mortality, and with the risk of mechani...
Main Authors: | Izzet Altintas, Jesper Eugen-Olsen, Santeri Seppälä, Jens Tingleff, Marius Ahm Stauning, Nora Olsen El Caidi, Sanaá Elmajdoubi, Hejdi Gamst-Jensen, Mette B Lindstrøm, Line Jee Hartmann Rasmussen, Klaus Tjelle Kristiansen, Christian Rasmussen, Jan O Nehlin, Thomas Kallemose, Harri Hyppölä, Ove Andersen |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-08-01
|
Series: | Biomarker Insights |
Online Access: | https://doi.org/10.1177/11772719211034685 |
Similar Items
-
Healthy lifestyles reduce suPAR and mortality in a Danish general population study
by: Thomas Huneck Haupt, et al.
Published: (2019-01-01) -
Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients
by: Esben Iversen, et al.
Published: (2020-06-01) -
The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma – a retrospective cohort study
by: K. E. J. Håkansson, et al.
Published: (2019-11-01) -
suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients
by: Jeppe Meyer, et al.
Published: (2018-02-01) -
High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD
by: Håkansson KEJ, et al.
Published: (2020-04-01)